Table 3. Effect of various ascorbic acid level on sperm quality after thawing
Treatment1) | Sperm motility | Sperm viability | Sperm abnormality | PMI |
C0 (0%) | 50.14 ± 1.57ab2) | 57.43 ± 1.27ab | 28.57 ± 2.07 | 58.14 ± 1.77ab |
C1 (1%) | 52.14 ± 2.27bcd | 59.43 ± 2.23bc | 24.29 ± 2.69 | 59.86 ± 1.66bc |
C2 (2%) | 54.43 ± 1.28cd | 61.43 ± 2.37cd | 25.86 ± 2.12 | 59.00 ± 1.41bc |
C3 (3%) | 56.00 ± 3.11d | 63.14 ± 2.47cd | 27.14 ± 1.22 | 62.86 ± 1.95de |
C4 (4%) | 53.57 ± 3.21bcd | 61.14 ± 1.95d | 26.00 ± 1.82 | 63.57 ± 2.25e |
C0 without addition of ascorbic acids; C1, with addition of 1 mg ascorbic acid into 100 mL extender; C2, with addition of 2 mg ascorbic acid into 100 mL extender; C3, with addition of 3 mg ascorbic acid into 100 mL extender, C4 with addition of 4 mg ascorbic acid into 100 mL extender.
Data show all mean ± standard error of means (n = 7).
Means in a column with different superscripts differ significantly at p < 0.05.
PMI, plasma membrane integrity.